We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
-0.1%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$1.4B
AUM Growth
+$27M
Cap. Flow
+$60.2M
Cap. Flow %
4.29%
Top 10 Hldgs %
30.66%
Holding
535
New
44
Increased
253
Reduced
157
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 19.13%
2 Financials 8.58%
3 Industrials 6.75%
4 Communication Services 6.29%
5 Energy 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
201
Boston Scientific
BSX
$65.8B
$1.08M 0.08%
17,273
+177
+1% +$14.2K
PSX icon
202
Phillips 66
PSX
$82.9B
$1.05M 0.08%
5,786
+939
+19% +$147K
TDG icon
203
TransDigm Group
TDG
$69.2B
$1.05M 0.07%
907
-29
-3% -$38K
SLB icon
204
SLB Ltd
SLB
$77.8B
$1.05M 0.07%
20,359
+2,097
+11% +$102K
WELL icon
205
Welltower
WELL
$178B
$1.04M 0.07%
5,268
+125
+2% +$24.7K
HCA icon
206
HCA Healthcare
HCA
$84.8B
$1.03M 0.07%
2,171
-10
-0.5% -$5.03K
BA icon
207
Boeing
BA
$165B
$1.02M 0.07%
5,107
+155
+3% +$35.3K
DHR icon
208
Danaher
DHR
$135B
$1.01M 0.07%
5,321
-411
-7% -$87.5K
CRWD icon
209
CrowdStrike
CRWD
$187B
$1.01M 0.07%
10,332
-984
-9% -$104K
BKR icon
210
Baker Hughes
BKR
$56.8B
$1M 0.07%
16,460
-3,793
-19% -$219K
ACN icon
211
Accenture
ACN
$89.9B
$975K 0.07%
4,915
-150
-3% -$35K
FITB
212
Fifth Third Bancorp
FITB
$52B
$970K 0.07%
20,872
+3,686
+21% +$182K
IVE icon
213
iShares S&P 500 Value ETF
IVE
$48.9B
$968K 0.07%
4,584
REGN icon
214
Regeneron Pharmaceuticals
REGN
$68.8B
$965K 0.07%
1,249
+4
+0.3% +$3.06K
PLD icon
215
Prologis
PLD
$138B
$963K 0.07%
7,283
-3,636
-33% -$486K
VRTX icon
216
Vertex Pharmaceuticals
VRTX
$121B
$962K 0.07%
2,155
KMI icon
217
Kinder Morgan
KMI
$73.1B
$952K 0.07%
28,395
-128
-0.4% -$4K
MSI icon
218
Motorola Solutions
MSI
$69.4B
$947K 0.07%
2,182
+88
+4% +$38.1K
PAA icon
219
Plains All American Pipeline
PAA
$17.4B
$938K 0.07%
+42,000
New +$854K
HESM icon
220
Hess Midstream
HESM
$5.22B
$933K 0.07%
+24,000
New +$889K
MRSH
221
Marsh
MRSH
$86.3B
$929K 0.07%
5,355
-201
-4% -$36.1K
SHY icon
222
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$926K 0.07%
11,217
IBB icon
223
iShares Biotechnology ETF
IBB
$9.31B
$913K 0.07%
5,408
+563
+12% +$96.3K
URA icon
224
Global X Uranium ETF
URA
$5.54B
$910K 0.06%
18,784
EZPW icon
225
Ezcorp Inc
EZPW
$1.82B
$904K 0.06%
35,609
+609
+2% +$14.6K

Similar funds

Fidelis Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Fidelis Capital Partners held 535 positions worth $1.4B, up 2% from $1.38B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fidelis Capital Partners deployed $60.2M of net new capital in Q1 2026, opening 44 new positions and adding to 253 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 24,768 shares worth $2.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Qualcomm, an estimated $1.52M trimmed.

  • Fidelis Capital Partners's largest Q1 2026 buy was SPDR Gold MiniShares Trust: 24,768 shares worth $2.3M.
  • Fidelis Capital Partners added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $8.5M increase.
  • Fidelis Capital Partners's biggest Q1 2026 reduction was Qualcomm, cutting an estimated $1.52M.
  • Fidelis Capital Partners fully exited Fidelity Low Duration Bond Factor ETF in Q1 2026, selling an estimated $1.74M.
  • Fidelis Capital Partners's ten largest holdings make up 31% of its $1.4B portfolio in Q1 2026.
  • Fidelis Capital Partners opened 44 new positions and closed 31 in Q1 2026.
  • Fidelis Capital Partners's portfolio value rose 2% quarter-over-quarter to $1.4B.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.